Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 3 |
iShares Silver Trust
SLV
|
+$1.03B |
| 4 |
Walmart Inc
WMT
|
+$862M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$850M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.99B |
| 2 |
Micron Technology
MU
|
+$1.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$772M |
| 4 |
Tesla
TSLA
|
+$700M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$639M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.77% |
| 2 | Healthcare | 1.08% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.94% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10551
Syntec Optics
OPTX
$355M
| $39.1K | ﹤0.01% |
13,684
+1,891
| +16% | +$3.8K |
|
|
OSTX
10552
OS Therapies Inc
OSTX
$74.9M
| $38.8K | ﹤0.01% |
+27,740
| New | +$50K |
|
10553
PUT
Absci
ABSI
$1.58B
| $38.7K | ﹤0.01% |
11,100
+400
| +4% | +$1.46K |
|
10554
PUT
Apyx Medical
APYX
$128M
| $38.5K | ﹤0.01% |
+11,000
| New | +$38.4K |
|
10555
CALL
Black Diamond Therapeutics
BDTX
$116M
| $38.4K | ﹤0.01% |
+15,800
| New | +$56K |
|
10556
Highway Holdings
HIHO
$4.95M
| $38.4K | ﹤0.01% |
+24,122
| New | +$33.8K |
|
|
FLD
10557
CALL
Fold Holdings
FLD
$26.1M
| $38.1K | ﹤0.01% |
+14,600
| New | +$48.3K |
|
|
CRDL
10558
Cardiol Therapeutics
CRDL
$207M
| $38K | ﹤0.01% |
39,828
-76,519
| -66% | -$80.1K |
|
|
ARAI
10559
Arrive AI Inc
ARAI
$13.1M
| $37.9K | ﹤0.01% |
14,425
-15,006
| -51% | -$62.8K |
|
|
FLX
10560
BingEx Ltd
FLX
$146M
| $37.5K | ﹤0.01% |
+11,793
| New | +$39.3K |
|
10561
CALL
Rezolute
RZLT
$443M
| $37.1K | ﹤0.01% |
+15,700
| New | +$123K |
|
10562
Castor Maritime
CTRM
$22.6M
| $37K | ﹤0.01% |
+17,898
| New | +$37.3K |
|
|
MEHA
10563
DELISTED
FUNCTIONAL BRANDS INC
MEHA
| $36.9K | ﹤0.01% |
+194,968
| New | +$89.1K |
|
10564
CALL
Coherus Oncology
CHRS
$185M
| $36.8K | ﹤0.01% |
25,900
-1,500
| -5% | -$2.19K |
|
10565
Heritage Global
HGBL
$37.8M
| $36.8K | ﹤0.01% |
29,651
+19,642
| +196% | +$27.3K |
|
10566
CALL
Outdoor Holding Co
POWW
$260M
| $36.8K | ﹤0.01% |
+21,500
| New | +$37K |
|
|
AGEN
10567
CALL
Agenus
AGEN
$329M
| $36.7K | ﹤0.01% |
11,700
-17,100
| -59% | -$68.1K |
|
10568
Sphere 3D
ANY
$18.1M
| $36.6K | ﹤0.01% |
+12,309
| New | +$73.7K |
|
10569
Alvotech Warrant
ALVOW
$57.4M
| $36.6K | ﹤0.01% |
56,252
-4
| -0% | -$4 |
|
|
ALPS
10570
ALPS Group Inc
ALPS
$53.2M
| $36.4K | ﹤0.01% |
+41,838
| New | +$43.6K |
|
10571
IRIDEX
IRIX
$14.9M
| $36.2K | ﹤0.01% |
31,758
+15,377
| +94% | +$15.8K |
|
|
ZENA
10572
PUT
ZenaTech Inc
ZENA
$190M
| $36.2K | ﹤0.01% |
11,300
-8,500
| -43% | -$35.4K |
|
10573
CALL
Equillium
EQ
$150M
| $36.1K | ﹤0.01% |
23,300
+5,400
| +30% | +$6.58K |
|
|
SGMO
10574
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $36K | ﹤0.01% |
85,600
+37,400
| +78% | +$19.8K |
|
10575
INmune Bio
INMB
$60.2M
| $35.8K | ﹤0.01% |
22,957
-26,617
| -54% | -$47.5K |
|
Similar funds
Jane Street's Q4 2025 Portfolio in Review
As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
- Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
- Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
- Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
- Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
- Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.